⭐ ⭐ ⭐ ⭐ ⭐ 4.9/19 Based on verified feedback
Cartalax (also known as AED, T-31, or AC-4) is a short, synthetic bioregulatory tripeptide (Alanine-Glutamic Acid-Aspartic Acid) originally developed by Russian researchers. It is primarily studied for its potential to support cartilage repair, joint health, and anti-aging at the cellular level.
How it Works (in preclinical studies)
Cartalax is a lab-made peptide bioregulator that contains a short amino acid sequence (AED) similar to a segment of type XI collagen found in human joint cartilage. In preclinical and animal studies, researchers hypothesize that it promotes joint health through several mechanisms:
Cartilage Maintenance: It may upregulate genes that support cartilage matrix synthesis and collagen production.
Inflammation Reduction: It has been observed to suppress pro-inflammatory cytokines, which helps reduce joint inflammation.
Cell Preservation: It can support chondrocyte (cartilage cell) survival, helping to reduce cellular breakdown.
The Science Behind Cartalax
How it works: Cartalax is a short synthetic peptide that mimics sequences found in type XI collagen. It aims to support the production of Type II collagen and lower inflammation at the cellular level.
Potential benefits: Some users report that peptide therapies help manage localized inflammation and can improve joint comfort within a few weeks.
How It Is Studied
Tissue Targeting: The amino acid sequence is believed to resemble a structural segment of type XI collagen, which is found naturally in cartilage and connective tissue.
Cell Signaling: Scientists hypothesize that Cartalax acts as a bioregulator that can enter cells and interact with DNA, potentially normalizing protein synthesis in chondrocytes (the cellsresponsible for maintaining cartilage).
ResearchApplications: In preclinical and in vitro laboratory research, it is investigated for its potential to modulate gene expression, reduce oxidative stress, and assist in tissue regeneration
Product Details:
• Compound: Cartalax
• Quantity: 20 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture
Research Use Only
This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.
This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.
By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.
⭐ ⭐ ⭐ ⭐ ⭐ 4.9/19 Based on verified feedback
Cartalax (also known as AED, T-31, or AC-4) is a short, synthetic bioregulatory tripeptide (Alanine-Glutamic Acid-Aspartic Acid) originally developed by Russian researchers. It is primarily studied for its potential to support cartilage repair, joint health, and anti-aging at the cellular level.
How it Works (in preclinical studies)
Cartalax is a lab-made peptide bioregulator that contains a short amino acid sequence (AED) similar to a segment of type XI collagen found in human joint cartilage. In preclinical and animal studies, researchers hypothesize that it promotes joint health through several mechanisms:
Cartilage Maintenance: It may upregulate genes that support cartilage matrix synthesis and collagen production.
Inflammation Reduction: It has been observed to suppress pro-inflammatory cytokines, which helps reduce joint inflammation.
Cell Preservation: It can support chondrocyte (cartilage cell) survival, helping to reduce cellular breakdown.
The Science Behind Cartalax
How it works: Cartalax is a short synthetic peptide that mimics sequences found in type XI collagen. It aims to support the production of Type II collagen and lower inflammation at the cellular level.
Potential benefits: Some users report that peptide therapies help manage localized inflammation and can improve joint comfort within a few weeks.
How It Is Studied
Tissue Targeting: The amino acid sequence is believed to resemble a structural segment of type XI collagen, which is found naturally in cartilage and connective tissue.
Cell Signaling: Scientists hypothesize that Cartalax acts as a bioregulator that can enter cells and interact with DNA, potentially normalizing protein synthesis in chondrocytes (the cellsresponsible for maintaining cartilage).
ResearchApplications: In preclinical and in vitro laboratory research, it is investigated for its potential to modulate gene expression, reduce oxidative stress, and assist in tissue regeneration
Product Details:
• Compound: Cartalax
• Quantity: 20 mg
• Form: Lyophilized Powder
• Purity: ≥99% (if applicable)
• Storage: Store in a controlled laboratory environment, protected from light and moisture
Research Use Only
This product is intended strictly for laboratory research use only.
Not for human consumption.
Not for medical use.
Not intended to diagnose, treat, cure, or prevent any disease.
Not approved by the FDA.
This product is in powder form and is not reconstituted. All materials sold on this site are for laboratory research purposes only and are subject to our Terms and Conditions.
By purchasing, the buyer confirms this product will be used strictly for laboratory research purposes.
